Valuation: Gedeon Richter

Market Cap 2,276B 7.09B 6.22B 5.88B 5.36B 10.02B 680B 10.1B 70.32B 27.24B 347B 26.62B 26.05B 1,116B P/E 2026 *
9.18x
P/E 2027 * 7.85x
Enterprise Value 2,014B 6.27B 5.5B 5.2B 4.74B 8.87B 601B 8.93B 62.21B 24.1B 307B 23.55B 23.04B 987B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.83x
Free-Float
72.87%
Yield 2026 *
4.84%
Yield 2027 * 5.42%
3 years 23.55
Extreme 23.55
30.92
5 years 17.54
Extreme 17.54
30.92
10 years 17.54
Extreme 17.54
30.92
Manager TitleAgeSince
Chief Executive Officer 47 01/11/2017
Director of Finance/CFO - 01/05/2025
Chief Operating Officer - 01/01/2019
Director TitleAgeSince
Chairman 78 01/01/2017
Chairman 90 01/03/2024
Director/Board Member 65 26/04/2012
Change 5-day change 1-year change 3-year change Capi.($)
+24.45%-.--% - - 7.09B
+0.12%+0.81%+13.81%+64.78% 46.37B
+1.09%+0.36%+39.50%+107.67% 37.26B
+2.00%+3.78%+18.12%+99.54% 12.53B
+0.05%+0.37%-7.29%+18.68% 11.8B
0.00%0.00%+18.72%+139.63% 8.97B
-1.34%-2.73%+27.67%+37.52% 7.09B
-2.07%-2.75%+17.20%+202.97% 7.01B
+1.43%+2.22%+43.10%-14.21% 7.29B
-2.45%-0.59%-51.49%+4.53% 4.99B
Average +2.33%+0.16%+13.26%+73.46% 15.92B
Weighted average by Cap. +1.46%+0.54%+19.51%+79.15%

Financials

2026 *2027 *
Net sales 951B 2.96B 2.6B 2.46B 2.24B 4.19B 284B 4.22B 29.39B 11.38B 145B 11.13B 10.89B 466B 1,021B 3.18B 2.79B 2.64B 2.4B 4.5B 305B 4.53B 31.54B 12.21B 156B 11.94B 11.68B 500B
Net income 254B 792M 695M 657M 598M 1.12B 75.92B 1.13B 7.86B 3.04B 38.79B 2.97B 2.91B 125B 291B 905M 794M 750M 684M 1.28B 86.74B 1.29B 8.98B 3.48B 44.32B 3.4B 3.32B 142B
Net Debt -262B -818M -717M -678M -618M -1.16B -78.36B -1.16B -8.11B -3.14B -40.03B -3.07B -3B -129B -410B -1.28B -1.12B -1.06B -965M -1.81B -122B -1.82B -12.67B -4.91B -62.54B -4.8B -4.69B -201B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
11,155
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,480.00HUF
Average target price
13,214.57HUF
Spread / Average Target
+5.89%

Quarterly revenue - Rate of surprise